Healthcare -
Biotechnology - NASDAQ - US
$ 41.1
1.61 %
$ 2.66 B
Market Cap
-17.56
P/E
KYMR - ACCOUNTS PAYABLE
Accounts Payable KYMR - Kymera Therapeutics, Inc.
7.08 M
LAST VALUE
32.91%
2 YEAR CAGR
28.04%
5 YEAR CAGR
0.00%
10 YEAR CAGR